nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketamine—CYP2C9—brain cancer	0.646	1	CbGaD
Ketamine—CYP3A4—Temozolomide—brain cancer	0.0361	0.264	CbGbCtD
Ketamine—PTGS1—Etoposide—brain cancer	0.0317	0.232	CbGbCtD
Ketamine—CYP3A4—Lomustine—brain cancer	0.0307	0.225	CbGbCtD
Ketamine—CYP2C8—Etoposide—brain cancer	0.0183	0.134	CbGbCtD
Ketamine—ABCB1—Etoposide—brain cancer	0.0124	0.0906	CbGbCtD
Ketamine—TACR1—trigeminal nerve—brain cancer	0.0101	0.0637	CbGeAlD
Ketamine—CYP3A4—Etoposide—brain cancer	0.00741	0.0543	CbGbCtD
Ketamine—TACR1—cranial nerve—brain cancer	0.00717	0.0454	CbGeAlD
Ketamine—GRIN1—telencephalic ventricle—brain cancer	0.00638	0.0403	CbGeAlD
Ketamine—GRIN2B—telencephalic ventricle—brain cancer	0.00608	0.0385	CbGeAlD
Ketamine—GRIN1—ganglion—brain cancer	0.00397	0.0251	CbGeAlD
Ketamine—GRIN2B—ganglion—brain cancer	0.00379	0.0239	CbGeAlD
Ketamine—GRIN2C—hindbrain—brain cancer	0.00363	0.023	CbGeAlD
Ketamine—TACR1—ganglion—brain cancer	0.00363	0.023	CbGeAlD
Ketamine—GRIN2D—hindbrain—brain cancer	0.00338	0.0214	CbGeAlD
Ketamine—GRIN2A—ganglion—brain cancer	0.00331	0.0209	CbGeAlD
Ketamine—OPRM1—telencephalic ventricle—brain cancer	0.00323	0.0204	CbGeAlD
Ketamine—GRIN1—hindbrain—brain cancer	0.00301	0.019	CbGeAlD
Ketamine—OPRD1—ganglion—brain cancer	0.00295	0.0187	CbGeAlD
Ketamine—GRIN2B—hindbrain—brain cancer	0.00287	0.0182	CbGeAlD
Ketamine—GRIN2A—hindbrain—brain cancer	0.00251	0.0159	CbGeAlD
Ketamine—DRD2—telencephalic ventricle—brain cancer	0.00216	0.0136	CbGeAlD
Ketamine—GRIN2C—brainstem—brain cancer	0.00208	0.0132	CbGeAlD
Ketamine—OPRM1—ganglion—brain cancer	0.00201	0.0127	CbGeAlD
Ketamine—GRIN2D—brainstem—brain cancer	0.00194	0.0122	CbGeAlD
Ketamine—GRIN2C—telencephalon—brain cancer	0.00185	0.0117	CbGeAlD
Ketamine—GRIN1—brainstem—brain cancer	0.00173	0.0109	CbGeAlD
Ketamine—GRIN2D—telencephalon—brain cancer	0.00172	0.0109	CbGeAlD
Ketamine—GRIN2B—brainstem—brain cancer	0.00165	0.0104	CbGeAlD
Ketamine—GRIN3A—telencephalon—brain cancer	0.00162	0.0102	CbGeAlD
Ketamine—TACR1—brainstem—brain cancer	0.00158	0.00998	CbGeAlD
Ketamine—GRIN1—telencephalon—brain cancer	0.00153	0.00968	CbGeAlD
Ketamine—SLC6A2—ganglion—brain cancer	0.00147	0.00932	CbGeAlD
Ketamine—GRIN2B—telencephalon—brain cancer	0.00146	0.00924	CbGeAlD
Ketamine—GRIN2C—medulla oblongata—brain cancer	0.00145	0.00918	CbGeAlD
Ketamine—GRIN2A—brainstem—brain cancer	0.00144	0.0091	CbGeAlD
Ketamine—TACR1—telencephalon—brain cancer	0.0014	0.00886	CbGeAlD
Ketamine—GRIN2D—medulla oblongata—brain cancer	0.00135	0.00854	CbGeAlD
Ketamine—DRD2—ganglion—brain cancer	0.00134	0.00849	CbGeAlD
Ketamine—Nystagmus—Procarbazine—brain cancer	0.00133	0.0786	CcSEcCtD
Ketamine—GRIN2A—telencephalon—brain cancer	0.00128	0.00807	CbGeAlD
Ketamine—GRIN2D—spinal cord—brain cancer	0.0012	0.00761	CbGeAlD
Ketamine—GRIN2C—head—brain cancer	0.00115	0.00728	CbGeAlD
Ketamine—OPRD1—telencephalon—brain cancer	0.00114	0.0072	CbGeAlD
Ketamine—GRIN1—midbrain—brain cancer	0.0011	0.00695	CbGeAlD
Ketamine—GRIN1—spinal cord—brain cancer	0.00107	0.00678	CbGeAlD
Ketamine—GRIN2D—head—brain cancer	0.00107	0.00677	CbGeAlD
Ketamine—GRIN2C—central nervous system—brain cancer	0.00105	0.00664	CbGeAlD
Ketamine—GRIN2C—cerebellum—brain cancer	0.00103	0.00649	CbGeAlD
Ketamine—GRIN2B—spinal cord—brain cancer	0.00102	0.00647	CbGeAlD
Ketamine—DRD2—hindbrain—brain cancer	0.00102	0.00644	CbGeAlD
Ketamine—GRIN3A—head—brain cancer	0.00101	0.00636	CbGeAlD
Ketamine—GRIN2A—medulla oblongata—brain cancer	0.001	0.00634	CbGeAlD
Ketamine—PTGS1—ganglion—brain cancer	0.000981	0.00621	CbGeAlD
Ketamine—TACR1—spinal cord—brain cancer	0.000981	0.00621	CbGeAlD
Ketamine—GRIN2D—central nervous system—brain cancer	0.000976	0.00618	CbGeAlD
Ketamine—GRIN1—endocrine gland—brain cancer	0.000966	0.00611	CbGeAlD
Ketamine—GRIN2D—cerebellum—brain cancer	0.000954	0.00604	CbGeAlD
Ketamine—GRIN1—head—brain cancer	0.000953	0.00603	CbGeAlD
Ketamine—GRIN2B—endocrine gland—brain cancer	0.000921	0.00583	CbGeAlD
Ketamine—GRIN3A—central nervous system—brain cancer	0.000918	0.00581	CbGeAlD
Ketamine—GRIN2A—midbrain—brain cancer	0.000917	0.0058	CbGeAlD
Ketamine—GRIN2B—head—brain cancer	0.000909	0.00575	CbGeAlD
Ketamine—GRIN2A—spinal cord—brain cancer	0.000894	0.00566	CbGeAlD
Ketamine—TACR1—endocrine gland—brain cancer	0.000883	0.00559	CbGeAlD
Ketamine—OPRM1—brainstem—brain cancer	0.000874	0.00553	CbGeAlD
Ketamine—TACR1—head—brain cancer	0.000872	0.00552	CbGeAlD
Ketamine—GRIN1—central nervous system—brain cancer	0.00087	0.0055	CbGeAlD
Ketamine—GRIN1—cerebellum—brain cancer	0.000851	0.00538	CbGeAlD
Ketamine—PTGS1—endothelium—brain cancer	0.000846	0.00535	CbGeAlD
Ketamine—GRIN2C—brain—brain cancer	0.000834	0.00527	CbGeAlD
Ketamine—GRIN2B—central nervous system—brain cancer	0.00083	0.00525	CbGeAlD
Ketamine—GRIN2B—cerebellum—brain cancer	0.000811	0.00513	CbGeAlD
Ketamine—GRIN2A—endocrine gland—brain cancer	0.000805	0.00509	CbGeAlD
Ketamine—TACR1—central nervous system—brain cancer	0.000796	0.00503	CbGeAlD
Ketamine—GRIN2A—head—brain cancer	0.000795	0.00503	CbGeAlD
Ketamine—PTGS1—blood vessel—brain cancer	0.00078	0.00494	CbGeAlD
Ketamine—OPRM1—telencephalon—brain cancer	0.000776	0.00491	CbGeAlD
Ketamine—GRIN2D—brain—brain cancer	0.000775	0.0049	CbGeAlD
Ketamine—GRIN3A—brain—brain cancer	0.000729	0.00461	CbGeAlD
Ketamine—GRIN2A—central nervous system—brain cancer	0.000726	0.00459	CbGeAlD
Ketamine—GRIN2A—cerebellum—brain cancer	0.000709	0.00449	CbGeAlD
Ketamine—OPRD1—head—brain cancer	0.000709	0.00448	CbGeAlD
Ketamine—GRIN1—brain—brain cancer	0.000691	0.00437	CbGeAlD
Ketamine—Diplopia—Procarbazine—brain cancer	0.000689	0.0408	CcSEcCtD
Ketamine—OPRK1—head—brain cancer	0.000679	0.0043	CbGeAlD
Ketamine—GRIN2B—brain—brain cancer	0.000659	0.00417	CbGeAlD
Ketamine—OPRD1—central nervous system—brain cancer	0.000647	0.00409	CbGeAlD
Ketamine—SLC6A2—brainstem—brain cancer	0.00064	0.00405	CbGeAlD
Ketamine—TACR1—brain—brain cancer	0.000632	0.004	CbGeAlD
Ketamine—OPRK1—central nervous system—brain cancer	0.00062	0.00392	CbGeAlD
Ketamine—Laryngospasm—Etoposide—brain cancer	0.000615	0.0364	CcSEcCtD
Ketamine—OPRK1—cerebellum—brain cancer	0.000606	0.00383	CbGeAlD
Ketamine—DRD2—brainstem—brain cancer	0.000583	0.00369	CbGeAlD
Ketamine—GRIN2A—brain—brain cancer	0.000576	0.00364	CbGeAlD
Ketamine—SLC6A2—telencephalon—brain cancer	0.000568	0.00359	CbGeAlD
Ketamine—OPRM1—midbrain—brain cancer	0.000557	0.00353	CbGeAlD
Ketamine—OPRM1—spinal cord—brain cancer	0.000544	0.00344	CbGeAlD
Ketamine—Apnoea—Etoposide—brain cancer	0.000542	0.032	CcSEcCtD
Ketamine—Pain—Carboplatin—brain cancer	0.000522	0.0308	CcSEcCtD
Ketamine—DRD2—telencephalon—brain cancer	0.000518	0.00328	CbGeAlD
Ketamine—OPRD1—brain—brain cancer	0.000513	0.00325	CbGeAlD
Ketamine—Anorexia—Lomustine—brain cancer	0.000509	0.0301	CcSEcCtD
Ketamine—OPRK1—brain—brain cancer	0.000492	0.00311	CbGeAlD
Ketamine—OPRM1—endocrine gland—brain cancer	0.000489	0.0031	CbGeAlD
Ketamine—OPRM1—head—brain cancer	0.000483	0.00306	CbGeAlD
Ketamine—SLC6A2—gonad—brain cancer	0.000474	0.003	CbGeAlD
Ketamine—Decreased appetite—Lomustine—brain cancer	0.000464	0.0274	CcSEcCtD
Ketamine—ABCB1—blood vessel—brain cancer	0.000461	0.00292	CbGeAlD
Ketamine—SLC6A2—medulla oblongata—brain cancer	0.000446	0.00282	CbGeAlD
Ketamine—OPRM1—central nervous system—brain cancer	0.000441	0.00279	CbGeAlD
Ketamine—Diplopia—Carmustine—brain cancer	0.000431	0.0255	CcSEcCtD
Ketamine—Arrhythmia—Procarbazine—brain cancer	0.000426	0.0252	CcSEcCtD
Ketamine—DRD2—pituitary gland—brain cancer	0.000422	0.00267	CbGeAlD
Ketamine—Diplopia—Temozolomide—brain cancer	0.000417	0.0246	CcSEcCtD
Ketamine—CYP2C8—pituitary gland—brain cancer	0.00038	0.0024	CbGeAlD
Ketamine—PTGS1—telencephalon—brain cancer	0.000379	0.00239	CbGeAlD
Ketamine—DRD2—midbrain—brain cancer	0.000372	0.00235	CbGeAlD
Ketamine—Convulsion—Procarbazine—brain cancer	0.00036	0.0213	CcSEcCtD
Ketamine—SLC6A2—endocrine gland—brain cancer	0.000358	0.00227	CbGeAlD
Ketamine—SLC6A2—head—brain cancer	0.000354	0.00224	CbGeAlD
Ketamine—OPRM1—brain—brain cancer	0.00035	0.00221	CbGeAlD
Ketamine—CYP2B6—gonad—brain cancer	0.000349	0.00221	CbGeAlD
Ketamine—Vomiting—Lomustine—brain cancer	0.000339	0.0201	CcSEcCtD
Ketamine—Shock—Procarbazine—brain cancer	0.000333	0.0197	CcSEcCtD
Ketamine—DRD2—endocrine gland—brain cancer	0.000327	0.00207	CbGeAlD
Ketamine—SLC6A2—central nervous system—brain cancer	0.000323	0.00204	CbGeAlD
Ketamine—Anorexia—Procarbazine—brain cancer	0.000323	0.0191	CcSEcCtD
Ketamine—DRD2—head—brain cancer	0.000322	0.00204	CbGeAlD
Ketamine—Erythema—Hydroxyurea—brain cancer	0.000321	0.019	CcSEcCtD
Ketamine—Nausea—Lomustine—brain cancer	0.000317	0.0187	CcSEcCtD
Ketamine—Hypotension—Procarbazine—brain cancer	0.000317	0.0187	CcSEcCtD
Ketamine—PTGS1—pituitary gland—brain cancer	0.000308	0.00195	CbGeAlD
Ketamine—Decreased appetite—Procarbazine—brain cancer	0.000294	0.0174	CcSEcCtD
Ketamine—CYP2C8—endocrine gland—brain cancer	0.000294	0.00186	CbGeAlD
Ketamine—DRD2—central nervous system—brain cancer	0.000294	0.00186	CbGeAlD
Ketamine—Pain—Procarbazine—brain cancer	0.00029	0.0171	CcSEcCtD
Ketamine—DRD2—cerebellum—brain cancer	0.000288	0.00182	CbGeAlD
Ketamine—Convulsion—Hydroxyurea—brain cancer	0.000278	0.0165	CcSEcCtD
Ketamine—Arrhythmia—Carmustine—brain cancer	0.000267	0.0158	CcSEcCtD
Ketamine—PTGS1—spinal cord—brain cancer	0.000265	0.00168	CbGeAlD
Ketamine—CYP2B6—endocrine gland—brain cancer	0.000264	0.00167	CbGeAlD
Ketamine—CYP2C9—endocrine gland—brain cancer	0.000262	0.00165	CbGeAlD
Ketamine—CYP2B6—head—brain cancer	0.000261	0.00165	CbGeAlD
Ketamine—Erythema—Carmustine—brain cancer	0.00026	0.0154	CcSEcCtD
Ketamine—SLC6A2—brain—brain cancer	0.000256	0.00162	CbGeAlD
Ketamine—Erythema—Temozolomide—brain cancer	0.000251	0.0148	CcSEcCtD
Ketamine—Anorexia—Hydroxyurea—brain cancer	0.00025	0.0148	CcSEcCtD
Ketamine—Vision blurred—Carmustine—brain cancer	0.000245	0.0145	CcSEcCtD
Ketamine—PTGS1—endocrine gland—brain cancer	0.000239	0.00151	CbGeAlD
Ketamine—CYP2B6—central nervous system—brain cancer	0.000238	0.00151	CbGeAlD
Ketamine—Vision blurred—Temozolomide—brain cancer	0.000237	0.014	CcSEcCtD
Ketamine—PTGS1—head—brain cancer	0.000236	0.00149	CbGeAlD
Ketamine—DRD2—brain—brain cancer	0.000234	0.00148	CbGeAlD
Ketamine—Decreased appetite—Hydroxyurea—brain cancer	0.000228	0.0135	CcSEcCtD
Ketamine—Convulsion—Carmustine—brain cancer	0.000225	0.0133	CcSEcCtD
Ketamine—Pain—Hydroxyurea—brain cancer	0.000224	0.0133	CcSEcCtD
Ketamine—ABCB1—telencephalon—brain cancer	0.000224	0.00142	CbGeAlD
Ketamine—Convulsion—Temozolomide—brain cancer	0.000217	0.0129	CcSEcCtD
Ketamine—Vomiting—Procarbazine—brain cancer	0.000215	0.0127	CcSEcCtD
Ketamine—PTGS1—central nervous system—brain cancer	0.000215	0.00136	CbGeAlD
Ketamine—Rash—Procarbazine—brain cancer	0.000214	0.0126	CcSEcCtD
Ketamine—Dermatitis—Procarbazine—brain cancer	0.000213	0.0126	CcSEcCtD
Ketamine—CYP2C8—brain—brain cancer	0.000211	0.00133	CbGeAlD
Ketamine—Anaphylactic shock—Temozolomide—brain cancer	0.000205	0.0121	CcSEcCtD
Ketamine—Anorexia—Carmustine—brain cancer	0.000202	0.0119	CcSEcCtD
Ketamine—Nausea—Procarbazine—brain cancer	0.000201	0.0119	CcSEcCtD
Ketamine—CYP3A4—endocrine gland—brain cancer	0.000199	0.00126	CbGeAlD
Ketamine—Hypotension—Carmustine—brain cancer	0.000198	0.0117	CcSEcCtD
Ketamine—Anorexia—Temozolomide—brain cancer	0.000195	0.0115	CcSEcCtD
Ketamine—CYP2B6—brain—brain cancer	0.000189	0.0012	CbGeAlD
Ketamine—ABCB1—gonad—brain cancer	0.000187	0.00118	CbGeAlD
Ketamine—Decreased appetite—Carmustine—brain cancer	0.000184	0.0109	CcSEcCtD
Ketamine—ABCB1—pituitary gland—brain cancer	0.000182	0.00115	CbGeAlD
Ketamine—Pain—Carmustine—brain cancer	0.000181	0.0107	CcSEcCtD
Ketamine—CYP3A4—central nervous system—brain cancer	0.00018	0.00114	CbGeAlD
Ketamine—Decreased appetite—Temozolomide—brain cancer	0.000178	0.0105	CcSEcCtD
Ketamine—ABCB1—medulla oblongata—brain cancer	0.000176	0.00111	CbGeAlD
Ketamine—Pain—Temozolomide—brain cancer	0.000175	0.0104	CcSEcCtD
Ketamine—Convulsion—Etoposide—brain cancer	0.000174	0.0103	CcSEcCtD
Ketamine—PTGS1—brain—brain cancer	0.000171	0.00108	CbGeAlD
Ketamine—Vomiting—Hydroxyurea—brain cancer	0.000167	0.00986	CcSEcCtD
Ketamine—Rash—Hydroxyurea—brain cancer	0.000165	0.00977	CcSEcCtD
Ketamine—Dermatitis—Hydroxyurea—brain cancer	0.000165	0.00977	CcSEcCtD
Ketamine—Anaphylactic shock—Etoposide—brain cancer	0.000164	0.00969	CcSEcCtD
Ketamine—ABCB1—midbrain—brain cancer	0.000161	0.00102	CbGeAlD
Ketamine—ABCB1—spinal cord—brain cancer	0.000157	0.000992	CbGeAlD
Ketamine—Anorexia—Etoposide—brain cancer	0.000156	0.00924	CcSEcCtD
Ketamine—Nausea—Hydroxyurea—brain cancer	0.000156	0.00921	CcSEcCtD
Ketamine—Hypotension—Etoposide—brain cancer	0.000153	0.00906	CcSEcCtD
Ketamine—Decreased appetite—Etoposide—brain cancer	0.000142	0.00842	CcSEcCtD
Ketamine—ABCB1—endocrine gland—brain cancer	0.000141	0.000893	CbGeAlD
Ketamine—Pain—Etoposide—brain cancer	0.00014	0.00829	CcSEcCtD
Ketamine—ABCB1—head—brain cancer	0.000139	0.000881	CbGeAlD
Ketamine—Vomiting—Carmustine—brain cancer	0.000135	0.00797	CcSEcCtD
Ketamine—Rash—Carmustine—brain cancer	0.000134	0.0079	CcSEcCtD
Ketamine—Dermatitis—Carmustine—brain cancer	0.000134	0.00789	CcSEcCtD
Ketamine—Vomiting—Temozolomide—brain cancer	0.00013	0.0077	CcSEcCtD
Ketamine—Rash—Temozolomide—brain cancer	0.000129	0.00764	CcSEcCtD
Ketamine—Dermatitis—Temozolomide—brain cancer	0.000129	0.00763	CcSEcCtD
Ketamine—ABCB1—central nervous system—brain cancer	0.000127	0.000805	CbGeAlD
Ketamine—Nausea—Carmustine—brain cancer	0.000126	0.00744	CcSEcCtD
Ketamine—ABCB1—cerebellum—brain cancer	0.000124	0.000786	CbGeAlD
Ketamine—Nausea—Temozolomide—brain cancer	0.000122	0.00719	CcSEcCtD
Ketamine—Vomiting—Etoposide—brain cancer	0.000104	0.00616	CcSEcCtD
Ketamine—Rash—Etoposide—brain cancer	0.000103	0.00611	CcSEcCtD
Ketamine—Dermatitis—Etoposide—brain cancer	0.000103	0.0061	CcSEcCtD
Ketamine—ABCB1—brain—brain cancer	0.000101	0.000639	CbGeAlD
Ketamine—Nausea—Etoposide—brain cancer	9.74e-05	0.00576	CcSEcCtD
Ketamine—OPRM1—Signaling Pathways—PTCH2—brain cancer	3.61e-05	0.000849	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—DTX2—brain cancer	3.61e-05	0.000849	CbGpPWpGaD
Ketamine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—brain cancer	3.6e-05	0.000847	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—TRPC6—brain cancer	3.59e-05	0.000845	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	3.57e-05	0.00084	CbGpPWpGaD
Ketamine—GRIN1—Axon guidance—VEGFA—brain cancer	3.55e-05	0.000836	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—SMO—brain cancer	3.53e-05	0.000831	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—PTCH1—brain cancer	3.53e-05	0.000831	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—HES5—brain cancer	3.5e-05	0.000823	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—GLI1—brain cancer	3.47e-05	0.000817	CbGpPWpGaD
Ketamine—GRIN2B—Axon guidance—VEGFA—brain cancer	3.46e-05	0.000815	CbGpPWpGaD
Ketamine—TACR1—Signaling by GPCR—PIK3CG—brain cancer	3.46e-05	0.000814	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3.4e-05	0.0008	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—STRADA—brain cancer	3.4e-05	0.000799	CbGpPWpGaD
Ketamine—OPRD1—GPCR downstream signaling—VAV1—brain cancer	3.38e-05	0.000795	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—NOTCH2—brain cancer	3.38e-05	0.000794	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—ABR—brain cancer	3.35e-05	0.000789	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—TRPC6—brain cancer	3.34e-05	0.000787	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	3.32e-05	0.000781	CbGpPWpGaD
Ketamine—GRIN1—Developmental Biology—RELA—brain cancer	3.31e-05	0.000779	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—SUFU—brain cancer	3.29e-05	0.000774	CbGpPWpGaD
Ketamine—GRIN1—Developmental Biology—ERBB2—brain cancer	3.29e-05	0.000774	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—GLI2—brain cancer	3.24e-05	0.000762	CbGpPWpGaD
Ketamine—GRIN2B—Developmental Biology—RELA—brain cancer	3.23e-05	0.000759	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—VAV1—brain cancer	3.22e-05	0.000757	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—CYP2C9—brain cancer	3.21e-05	0.000755	CbGpPWpGaD
Ketamine—GRIN2B—Developmental Biology—ERBB2—brain cancer	3.21e-05	0.000755	CbGpPWpGaD
Ketamine—GRIN1—Axon guidance—EGFR—brain cancer	3.2e-05	0.000752	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—GFAP—brain cancer	3.18e-05	0.000747	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	3.16e-05	0.000744	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—SHH—brain cancer	3.15e-05	0.000741	CbGpPWpGaD
Ketamine—ABCB1—Allograft Rejection—VEGFA—brain cancer	3.12e-05	0.000734	CbGpPWpGaD
Ketamine—GRIN2B—Axon guidance—EGFR—brain cancer	3.12e-05	0.000733	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—VAV1—brain cancer	3.07e-05	0.000722	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—GLI1—brain cancer	3.05e-05	0.000716	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—TRPC6—brain cancer	3.04e-05	0.000714	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—HEY1—brain cancer	3.01e-05	0.000708	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—PTCH1—brain cancer	2.99e-05	0.000702	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—SMO—brain cancer	2.99e-05	0.000702	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—VAV1—brain cancer	2.96e-05	0.000697	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—DLL1—brain cancer	2.95e-05	0.000694	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—SUFU—brain cancer	2.89e-05	0.000679	CbGpPWpGaD
Ketamine—GRIN1—Developmental Biology—CTNNB1—brain cancer	2.88e-05	0.000677	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—ABR—brain cancer	2.83e-05	0.000667	CbGpPWpGaD
Ketamine—GRIN2B—Developmental Biology—CTNNB1—brain cancer	2.81e-05	0.00066	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—GFAP—brain cancer	2.79e-05	0.000655	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.77e-05	0.000651	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—HES1—brain cancer	2.77e-05	0.000651	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—GLI2—brain cancer	2.74e-05	0.000644	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—PTCH2—brain cancer	2.74e-05	0.000644	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	2.74e-05	0.000643	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—BSG—brain cancer	2.73e-05	0.000642	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—VAV1—brain cancer	2.69e-05	0.000633	CbGpPWpGaD
Ketamine—TACR1—GPCR downstream signaling—IL2—brain cancer	2.68e-05	0.000631	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—HES5—brain cancer	2.65e-05	0.000623	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—HEY1—brain cancer	2.64e-05	0.000621	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—PDGFRA—brain cancer	2.64e-05	0.00062	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—DLL1—brain cancer	2.59e-05	0.000609	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	2.58e-05	0.000606	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—GLI1—brain cancer	2.57e-05	0.000605	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—STRADA—brain cancer	2.57e-05	0.000605	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—SPP1—brain cancer	2.56e-05	0.000602	CbGpPWpGaD
Ketamine—GRIN1—Developmental Biology—VEGFA—brain cancer	2.54e-05	0.000596	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—TRPC6—brain cancer	2.53e-05	0.000596	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—SHH—brain cancer	2.51e-05	0.00059	CbGpPWpGaD
Ketamine—GRIN1—Developmental Biology—STAT3—brain cancer	2.51e-05	0.00059	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—VAV1—brain cancer	2.51e-05	0.000589	CbGpPWpGaD
Ketamine—GRIN2B—Developmental Biology—VEGFA—brain cancer	2.47e-05	0.000581	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—CYP2C9—brain cancer	2.45e-05	0.000576	CbGpPWpGaD
Ketamine—GRIN2B—Developmental Biology—STAT3—brain cancer	2.45e-05	0.000576	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—SUFU—brain cancer	2.44e-05	0.000574	CbGpPWpGaD
Ketamine—TACR1—Signaling by GPCR—IL2—brain cancer	2.44e-05	0.000573	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—TRPC6—brain cancer	2.42e-05	0.000569	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—SHH—brain cancer	2.39e-05	0.000561	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—PTCH1—brain cancer	2.38e-05	0.00056	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—SMO—brain cancer	2.38e-05	0.00056	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—GFAP—brain cancer	2.35e-05	0.000554	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—IDH1—brain cancer	2.35e-05	0.000552	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—IRS2—brain cancer	2.32e-05	0.000544	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—TRPC6—brain cancer	2.3e-05	0.000541	CbGpPWpGaD
Ketamine—GRIN1—Developmental Biology—EGFR—brain cancer	2.28e-05	0.000537	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—VAV1—brain cancer	2.28e-05	0.000535	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—SMO—brain cancer	2.26e-05	0.000532	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—PTCH1—brain cancer	2.26e-05	0.000532	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—HEY1—brain cancer	2.23e-05	0.000525	CbGpPWpGaD
Ketamine—GRIN2B—Developmental Biology—EGFR—brain cancer	2.22e-05	0.000523	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—SHH—brain cancer	2.2e-05	0.000518	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—DLL1—brain cancer	2.19e-05	0.000515	CbGpPWpGaD
Ketamine—ABCB1—Transmembrane transport of small molecules—TRPC6—brain cancer	2.15e-05	0.000505	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—ABR—brain cancer	2.15e-05	0.000505	CbGpPWpGaD
Ketamine—OPRD1—GPCR downstream signaling—PIK3CG—brain cancer	2.15e-05	0.000505	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—TRPC6—brain cancer	2.12e-05	0.000499	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—PTCH1—brain cancer	2.09e-05	0.000491	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—SMO—brain cancer	2.09e-05	0.000491	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—BSG—brain cancer	2.08e-05	0.00049	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—GLI2—brain cancer	2.07e-05	0.000488	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—CYP2C9—brain cancer	2.07e-05	0.000488	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—APC—brain cancer	2.04e-05	0.000481	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—PIK3CG—brain cancer	2.04e-05	0.000481	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	2e-05	0.00047	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—GLI1—brain cancer	1.95e-05	0.000459	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—PIK3CG—brain cancer	1.95e-05	0.000459	CbGpPWpGaD
Ketamine—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.91e-05	0.000449	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—NOTCH2—brain cancer	1.9e-05	0.000447	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—VAV1—brain cancer	1.9e-05	0.000447	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—PIK3CG—brain cancer	1.88e-05	0.000443	CbGpPWpGaD
Ketamine—TACR1—Signaling by GPCR—EGFR—brain cancer	1.86e-05	0.000438	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—SHH—brain cancer	1.86e-05	0.000438	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—ENO2—brain cancer	1.86e-05	0.000436	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—SUFU—brain cancer	1.85e-05	0.000435	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—VAV1—brain cancer	1.81e-05	0.000427	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—CYP2C9—brain cancer	1.81e-05	0.000425	CbGpPWpGaD
Ketamine—DRD2—Circadian rythm related genes—TP53—brain cancer	1.8e-05	0.000424	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—TRPC6—brain cancer	1.79e-05	0.000422	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—IDH1—brain cancer	1.79e-05	0.000421	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—GFAP—brain cancer	1.78e-05	0.00042	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	1.77e-05	0.000415	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—SMO—brain cancer	1.76e-05	0.000415	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—PTCH1—brain cancer	1.76e-05	0.000415	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—BSG—brain cancer	1.76e-05	0.000415	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	1.75e-05	0.000411	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—VAV1—brain cancer	1.72e-05	0.000406	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—PIK3CG—brain cancer	1.71e-05	0.000402	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—HEY1—brain cancer	1.69e-05	0.000398	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—NOTCH2—brain cancer	1.67e-05	0.000392	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—DLL1—brain cancer	1.66e-05	0.00039	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—RELA—brain cancer	1.6e-05	0.000376	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—PIK3CG—brain cancer	1.59e-05	0.000374	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—VAV1—brain cancer	1.59e-05	0.000374	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—ERBB2—brain cancer	1.59e-05	0.000373	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—HES1—brain cancer	1.56e-05	0.000367	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	1.54e-05	0.000362	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—BSG—brain cancer	1.54e-05	0.000361	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—IDH1—brain cancer	1.52e-05	0.000356	CbGpPWpGaD
Ketamine—OPRD1—GPCR downstream signaling—IL2—brain cancer	1.51e-05	0.000355	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—PDGFRA—brain cancer	1.49e-05	0.000349	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—PIK3CG—brain cancer	1.44e-05	0.00034	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—SPP1—brain cancer	1.44e-05	0.000339	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—IL2—brain cancer	1.44e-05	0.000338	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—BSG—brain cancer	1.43e-05	0.000337	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	1.42e-05	0.000333	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—ENO2—brain cancer	1.42e-05	0.000333	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—SHH—brain cancer	1.41e-05	0.000332	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—NOTCH2—brain cancer	1.41e-05	0.000332	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—CCND1—brain cancer	1.4e-05	0.00033	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—CTNNB1—brain cancer	1.39e-05	0.000327	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	1.39e-05	0.000326	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—IL2—brain cancer	1.37e-05	0.000323	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—HES1—brain cancer	1.37e-05	0.000322	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—TRPC6—brain cancer	1.36e-05	0.00032	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—VAV1—brain cancer	1.34e-05	0.000316	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—PTCH1—brain cancer	1.34e-05	0.000314	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—SMO—brain cancer	1.34e-05	0.000314	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—IL2—brain cancer	1.32e-05	0.000312	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—IDH1—brain cancer	1.32e-05	0.000311	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—IRS2—brain cancer	1.3e-05	0.000307	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—PDGFRA—brain cancer	1.3e-05	0.000306	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—SPP1—brain cancer	1.26e-05	0.000297	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.23e-05	0.00029	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—IDH1—brain cancer	1.23e-05	0.00029	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—VEGFA—brain cancer	1.22e-05	0.000288	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—STAT3—brain cancer	1.21e-05	0.000285	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—PIK3CG—brain cancer	1.21e-05	0.000284	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—IL2—brain cancer	1.2e-05	0.000283	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—ENO2—brain cancer	1.2e-05	0.000282	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	1.16e-05	0.000274	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—HES1—brain cancer	1.16e-05	0.000272	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—APC—brain cancer	1.15e-05	0.000271	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—PIK3CG—brain cancer	1.15e-05	0.000271	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—IRS2—brain cancer	1.14e-05	0.000269	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—MYC—brain cancer	1.13e-05	0.000265	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—IL2—brain cancer	1.12e-05	0.000263	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—CYP2C9—brain cancer	1.11e-05	0.000262	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—PDGFRA—brain cancer	1.1e-05	0.000259	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—EGFR—brain cancer	1.1e-05	0.000259	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—PIK3CG—brain cancer	1.1e-05	0.000258	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—SPP1—brain cancer	1.07e-05	0.000251	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—NOTCH2—brain cancer	1.07e-05	0.000251	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—EGFR—brain cancer	1.05e-05	0.000247	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—ENO2—brain cancer	1.04e-05	0.000245	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—VAV1—brain cancer	1.02e-05	0.00024	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—IL2—brain cancer	1.02e-05	0.000239	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—PIK3CG—brain cancer	1.01e-05	0.000238	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—APC—brain cancer	1.01e-05	0.000238	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1e-05	0.000236	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—ENO2—brain cancer	9.75e-06	0.000229	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—IRS2—brain cancer	9.66e-06	0.000227	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—BSG—brain cancer	9.46e-06	0.000223	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—TP53—brain cancer	9.24e-06	0.000217	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—EGFR—brain cancer	9.2e-06	0.000216	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—RELA—brain cancer	9e-06	0.000212	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—ERBB2—brain cancer	8.94e-06	0.00021	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—HES1—brain cancer	8.76e-06	0.000206	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—APC—brain cancer	8.54e-06	0.000201	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—PIK3CG—brain cancer	8.54e-06	0.000201	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—PIK3CG—brain cancer	8.51e-06	0.0002	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—IL2—brain cancer	8.49e-06	0.0002	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—PDGFRA—brain cancer	8.34e-06	0.000196	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—IDH1—brain cancer	8.14e-06	0.000191	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—IL2—brain cancer	8.1e-06	0.000191	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—SPP1—brain cancer	8.1e-06	0.00019	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—CCND1—brain cancer	7.9e-06	0.000186	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—RELA—brain cancer	7.89e-06	0.000186	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—ERBB2—brain cancer	7.84e-06	0.000184	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—CTNNB1—brain cancer	7.82e-06	0.000184	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—EGFR—brain cancer	7.78e-06	0.000183	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—IL2—brain cancer	7.71e-06	0.000181	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—IRS2—brain cancer	7.32e-06	0.000172	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—IL2—brain cancer	7.11e-06	0.000167	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—CCND1—brain cancer	6.93e-06	0.000163	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—VEGFA—brain cancer	6.89e-06	0.000162	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—CTNNB1—brain cancer	6.86e-06	0.000161	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—STAT3—brain cancer	6.82e-06	0.00016	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—RELA—brain cancer	6.67e-06	0.000157	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—ERBB2—brain cancer	6.63e-06	0.000156	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—PIK3CG—brain cancer	6.49e-06	0.000153	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—APC—brain cancer	6.47e-06	0.000152	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—PIK3CG—brain cancer	6.47e-06	0.000152	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—ENO2—brain cancer	6.43e-06	0.000151	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—MYC—brain cancer	6.34e-06	0.000149	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—EGFR—brain cancer	6.2e-06	0.000146	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—VEGFA—brain cancer	6.04e-06	0.000142	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—IL2—brain cancer	6.01e-06	0.000141	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—STAT3—brain cancer	5.98e-06	0.000141	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—EGFR—brain cancer	5.89e-06	0.000139	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CCND1—brain cancer	5.86e-06	0.000138	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CTNNB1—brain cancer	5.8e-06	0.000136	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—MYC—brain cancer	5.56e-06	0.000131	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—PIK3CG—brain cancer	5.5e-06	0.000129	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—EGFR—brain cancer	5.44e-06	0.000128	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—TP53—brain cancer	5.2e-06	0.000122	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—VEGFA—brain cancer	5.1e-06	0.00012	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—STAT3—brain cancer	5.05e-06	0.000119	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—RELA—brain cancer	5.05e-06	0.000119	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—ERBB2—brain cancer	5.02e-06	0.000118	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—PIK3CG—brain cancer	4.79e-06	0.000113	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—MYC—brain cancer	4.7e-06	0.00011	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—EGFR—brain cancer	4.59e-06	0.000108	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—TP53—brain cancer	4.56e-06	0.000107	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—IL2—brain cancer	4.55e-06	0.000107	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—PIK3CG—brain cancer	4.47e-06	0.000105	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CCND1—brain cancer	4.44e-06	0.000104	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CTNNB1—brain cancer	4.39e-06	0.000103	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—VEGFA—brain cancer	3.87e-06	9.1e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—TP53—brain cancer	3.86e-06	9.07e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—STAT3—brain cancer	3.83e-06	9.01e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—MYC—brain cancer	3.56e-06	8.37e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—EGFR—brain cancer	3.48e-06	8.19e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—PIK3CG—brain cancer	2.95e-06	6.94e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—TP53—brain cancer	2.92e-06	6.87e-05	CbGpPWpGaD
